Clinical Trial Update: Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 open-label continuation study of levodopa-carbidopa intestinal gel in advanced Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa-carbidopa intestinal gel (levodopa-carbidopa intestinal gel)

Snippet

Sponsor: AbbVie | Conditions: Advanced Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-12-02